COMMUNIQUÉS West-GlobeNewswire

Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering

22/04/2024 - 07:00

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva ® approved as one of first ustekinumab biosimilars in Europe EC approval based on robust development program confirming match to [...]

Ibogaine By David Dardashti' Investigates Correlation between Alcohol Addiction and Chemical Depression

22/04/2024 - 03:24

Ibogaine Clinic Aims to Create Sustainable Solutions to Treat Alcohol Addiction Miami, April 21, 2024 (GLOBE NEWSWIRE) -- The Ibogaine clinic by David Dardashti has announced its latest investigation into the [...]

Ibogaine By David Dardashti Offers New Treatment Procedure In Dedication Of Autism Awareness Month

22/04/2024 - 00:51

Ibogaine By David Dardashti Is Paving the Way For Autistic People With The Latest Treatment Procedure MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- To commemorate Autism Awareness Month, Ibogaine By David Dardashti is [...]

Ibogaine By David Dardashti Initiates Collaboration with Top Psychedelic Researchers

21/04/2024 - 23:48

Ibogaine By David Dardashti Seeks to Enhance Treatment Algorithms and Knowledge of Ibogaine MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a leading ibogaine provider in the world, is proud to [...]

Quantum Electrodynamics and Ibogaine: Enhancing Work Performance

21/04/2024 - 23:03

Ibogaine By David Dardashti claims improved treatment efficacy due to electromagnetic waves MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a leader in the field of ibogaine therapy, is [...]

Ibogaine By David Dardashti Encourages Patients to Practice Compassion

21/04/2024 - 22:07

Misty Huckabey explains how to Focus on Promoting Self-Love and Compassion MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, an organization that provides ibogaine-assisted addiction treatment, is [...]

Ibogaine By David Dardashti Offers Expanded Treatment Options

21/04/2024 - 19:26

Ibogaine By David Dardashti Enhances Treatment with Holistic Therapy Services MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce an expanded treatment program providing greater [...]

Ibogaine By David Dardashti Takes Pride in Participating in Sexual Awareness Month

21/04/2024 - 16:51

Clinic Works to Create New Solutions to Combat Sexual Assault MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is a specialized clinic that focuses on treating addiction, particularly in instances [...]

Ibogaine By David Dardashti Announces New Algorithm For Alcohol Addiction

21/04/2024 - 14:38

Revolutionary Method to Combat Alcoholism and Restore Quality of Life MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a prominent provider of natural and holistic remedies for substance abuse, has [...]

Ibogaine by David Dardashti Introduces New Algorithm for Methadone Addiction

21/04/2024 - 07:34

Algorithm Varies Slightly from Suboxone and Focuses on Continuously Dosed Ibogaine Treatment MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- The novel algorithm signifies a notable deviation from Suboxone, a frequently [...]

Ibogaine By David Dardashti Introduces New Algorithm for Depression Treatment

21/04/2024 - 07:04

A Revolutionary Advancement in Depression Treatments MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- In recent years, there has been a surge in clinical studies exploring the use of Ibogaine in treating depression. David [...]

Remedium Healthcare Products Launches NuVeria Labs' Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime

20/04/2024 - 01:44

Remedium Healthcare Products announces the launch of NuVeria Labs' Sacral Silicone Dressing on Amazon, setting a new standard in accessible, advanced wound care NORTHBROOK, Ill., April 19, 2024 (GLOBE NEWSWIRE) -- [...]

Vaxxinity Issues Shareholder Letter

20/04/2024 - 00:53

CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced [...]

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

19/04/2024 - 23:30

FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial [...]

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

19/04/2024 - 23:15

SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel [...]

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice

19/04/2024 - 23:10

SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the [...]

StateHouse Provides an Update on Application for Management Cease Trade Order

19/04/2024 - 23:00

SAN DIEGO and TORONTO, April 19, 2024 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc . (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQB: STHZF), a California-focused, vertically integrated cannabis company, today [...]

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

19/04/2024 - 22:30

NOVATO, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

19/04/2024 - 22:30

CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that, on April 15, 2024, the Company received a notification letter (the “Notice”) from the [...]